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Abstract
Background: Targeting stem cells holds great potential for studying the embryonic stem cell and development of stem cell-
based regenerative medicine. Previous studies demonstrated that nanoparticles can serve as a robust platform for gene
delivery, non-invasive cell imaging, and manipulation of stem cell differentiation. However specific targeting of embryonic
stem cells by peptide-linked nanoparticles has not been reported.
Methodology/Principal Findings: Here, we developed a method for screening peptides that specifically recognize rhesus
macaque embryonic stem cells by phage display and used the peptides to facilitate quantum dot targeting of embryonic
stem cells. Through a phage display screen, we found phages that displayed an APWHLSSQYSRT peptide showed high
affinity and specificity to undifferentiated primate embryonic stem cells in an enzyme-linked immunoabsorbent assay. These
results were subsequently confirmed by immunofluoresence microscopy. Additionally, this binding could be completed by
the chemically synthesized APWHLSSQYSRT peptide, indicating that the binding capability was specific and conferred by
the peptide sequence. Through the ligation of the peptide to CdSe-ZnS core-shell nanocrystals, we were able to, for the first
time, target embryonic stem cells through peptide-conjugated quantum dots.
Conclusions/Significance: These data demonstrate that our established method of screening for embryonic stem cell
specific binding peptides by phage display is feasible. Moreover, the peptide-conjugated quantum dots may be applicable
for embryonic stem cell study and utilization.
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Introduction
Embryonic stem (ES) cells hold great promise for replacement
therapies and studies of developmental biology, due to their ability
to differentiate to all lineages of cells while maintaining an
undifferentiated state during in vitro culture [1], [2], [3]. In ES cell
studies, it is critical to find specific markers for ES cells. Several
common makers for embryonic stem cells, such as Oct-4 and
SSEAs, have been reported; however, some of these markers are
not common for all ES cell lines [4], [5], [6]. Discovery of new ES
cell markers is critical not only for identification, isolation, and
visualization of ES cells, but also for potential clinical treatment as
a targeting agent.
Phage display is one of the most efficient methods to identify
novel biomarkers. The principle of the technology is based on
fusing nucleotide sequences of random polypeptides to that of a
phage coat protein which enables display of the chimeric proteins
on the phage surface. This method provides a direct link between
the selectable phenotype and reproducible genotype encoding for
that phenotype. By selection with the target of interest, a phage
pool that has increasing specific binding ability to the target can be
obtained efficiently. Phage display serves as a valuable tool for
selection of the new biomarkers for wide range of biomaterials [7],
[8], [9], [10]. Among all biomaterials targeted for phage display
selection, directly using whole cells as selection target has many
advantages: 1) it needs no further information about cell surface
molecules or purification of these molecules; 2) the surface
molecules are most likely in their original state; 3) the selection
stimulates the native binding environment where other macro-
molecules coexist. In this way, antibodies and peptides could be
directly and quickly generated from cell screening, which are
promising in the applications of cell labeling, gene delivery and
ligand stimulation [11]. So far, various novel peptides and
antibodies have been found using strategies of biopanning cells
in vitro [12], [13], [14], [15].
Nanoparticles are a promising platform for stem cell study and
manipulation [16]. The advantages of nanoparticles include large
absorption cross section, slow photo-bleaching and low cytotox-
PLoS ONE | www.plosone.org 1 August 2010 | Volume 5 | Issue 8 | e12075icity [17]. Recently, several groups have reported that nanopar-
ticles can be applicable to gene delivery, none-invasive imaging,
and differentiation manipulation of embryonic stem cells [18],
[19], [20], [21], [22], [23], [24], [25], [26]. Additionally, peptide-
conjugated quantum dots can be successfully used as for labeling
and targeting materials [27], [28]. However, the selectivity of
peptide and subsequent specificity of nanoparticle targeting are
still under investigation.
Here, we describe a method to screen for peptides that
specifically bind to ES cells by phage display. By using this
method, we found phages that display the APWHLSSQYSRT
peptide demonstrated a high affinity and specificity to the
undifferentiated embryonic stem cells in an enzyme-linked
immunosorbent assay (ELISA). To exclude non-specific binding,
we used the differentiated ES (dES) cells and primary mouse
e m b r y o n i cf i b r o b l a s t( P M E F )c e l l s ,af e e d e rl a y e rf o rt h e
maintenance pluripotency of embryonic stem cells, as a control.
Specific binding was further confirmed by immunofluoresence
microscopy. To investigate whether this binding was caused by
the displayed peptide rather than phage proteins, we chemically
synthesized a peptide bearing an identical sequence. The
competition experiment showed that the binding capability
was conferred by the peptide sequence. We subsequently ligated
the peptide to CdSe-ZnS core-shell nanocrystals. We found
these peptide-conjugated quantum dots were able to specifically
target the embryonic stem cells. We further showed that the
binding of the selected peptide to undifferentiated embryonic
stem cells was through a protein-protein interaction and that the
tertiary structure of the peptide determined by molecular
dynamic stimulation might provide an explanation for the
interaction.
Materials and Methods
Cell preparations
Rhesus monkey embryonic stem cell line RS366.4 (kindly
provided by Dr. James A. Thomson, The Wisconsin Regional
Primate Research Center, University of Wisconsin, US) and
mouse embryonic stem cell line M9 (kindly provided by Joint Lab
of Stem Cell Research, Graduate school at Shenzhen, Tsinghua
University, China) were plated on mitomycin treated PMEF cells,
and cultured in ES medium comprised of 85% DMEM (Hyclone,
Logan, UT), 1% nonessential amino acid (Gibco BRL, USA),
1 mM L-glutamine (Gibco BRL), 0.1 mM b-mercaptoethanol
(Amresco, Solon, Ohio), and 15% fetal bovine serum (FBS) (Gibco
BRL) as previously described [29]. For the characterization the
undifferentiated state of ES cells, alkaline phosphatase assay, RT-
PCR and immunofluorescence assay were performed. Alkaline
phosphatase assay of ES cells was performed following the
protocol as previous described [29]. For the RT-PCR assay, total
RNA from ES cells was extracted by Trizol (Gibco BRL), reverse
transcripted into cDNA by One-Step RNA PCR Kit (Takara) and
PCR amplified using the primers and conditions in Table S2.
Before selection by phages, ES cells were quickly detached by
dispase (Gibco BRL) (5mg/ml), washed twice with PBS, and
suspended in blocking buffer (PBS, 3% FBS) at 3610
6 cells/ml.
For the preparation of differentiated ES (dES) cells, ES cells were
harvested by digestion with dispase (5mg/ml). Detached ES cell
colonies were plated in 0.1% gelatin (Sigma) pre-coated T75 flasks
(Falcon, Becton Dickinson Labware, Franklin Lakes, NJ) and were
subsequently grown in differentiation medium which contains
90% DMEM (Hyclone, Logan, UT) and 10% newborn calf serum
(NCS) (Gibco BRL). After culture for two to three weeks, the ES
cells underwent spontaneous differentiation. The dES cells were
propagated and passaged by incubation with 0.05% trypsin/
0.53 mM EDTA. PMEFs were cultured and passaged as
previously described [29]. For preparation of phage display, dES
cells and PMEF cells were quickly digested with 0.05% trypsin/
0.53 mM EDTA, washed twice in PBS, and resuspended in
blocking buffer at 1610
6 cells/ml for dES cells and 5610
5 cells/ml
for PMEFs.
Phage peptide library selection
T h eP h . D - 1 2p e p t i d ep h a g ed i s p lay library was obtained from
New England Biolabs (Beijing, China). M13 Phages from the
Ph.D-12 library display 12 random amino acids at the N-
terminus of the pIII coat protein. Initially, approximately
1.5610
11 phages were added to 1 ml of dES cell suspension,
the mixture was subsequently incubated at room temperature
for 1 hr with slow shaking, followed by centrifugation at
3000 rpm for 3 min. The supernatant that contains phages
not binding to dES cells underwent two more subtractions with
dES cells, followed by three subtractions with PMEFs using the
same protocol. 1 ml of supernatant with subtracted phages were
titered to determine the efficiency of subtraction. The remaining
phages were mixed with 1 ml ES cell suspension, gently shaked
at room temperature for 90 min, washed 5 times with washing
buffer (PBS, 3% BSA, 0.1% Tween-20). For elution of specific
binding phage, 1.6 ml elution buffer (0.1 M glycine-HCl, 0.1%
BSA, pH 2.2) was added for no more than 10 min, and then was
neutralized with 0.3 ml 1 M Tris-HCl, pH 9.1. The eluted
phages were titered and amplified according to the manufac-
turer’s protocol. In total, four round biopannings were
performed in the same condition except that the concentration
of Tween-20 in elution buffer was gradually increased from
0.1% to 0.5%. The binding efficiency of the phage pool was
calculated by the ratio of its output phage number to input
phage number in each round selection, in order to survey the
effect of selection.
Sequencing of phage DNA
The selected phages described above were used to infect E.coli
strain ER2738, then the infected cells were plated, and
monoclonal phages were rescued from phage plaques; the DNA
from the amplified monoclonal phages were extracted and
sequenced following the manufacturer’s protocol. The corre-
sponding peptide sequences were analyzed for similarity between
themselves using Vector NTI software (Invitrogen).
Whole-cell ELISA
The binding ability and specificity of the selected phages to ES,
dES and PMEF cells were measured by enzyme linked
immunosorbent assay (ELISA). Confluent cells in 96-well plate
were fixed by 4% paraformaldehyde for 15 min, washed three
times with PBS, blocked with 250 ml blocking buffer (PBS, 3%
BSA), incubated at 37uC for 2 hrs, and washed three times with
PBS. Subsequently, 2610
9 phages in blocking buffer were added
and incubated for 90 min at room temperature. Then the plate
was washed three times with PBS, 0.1% Tween-20, another three
times with PBS, followed by incubation with HRP-conjugated
mouse anti-M13 antibody (1:1000 in blocking buffer) for 90 min at
room temperature. After three washes with PBS, 100 mlo -
phenylenediamine (OPD) substrate solution was added, and
incubated for 30 min in dark, before being quenched by 50 ml
2MH 2SO4. The absorbance was measured at 492 nm by a
GENios microplate reader (Tecan), and the absorbance at 405nm
was taken as a reference.
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synthesized oligopeptides
To analyze the binding ability of the selected phage to ES cells,
chemically synthetic peptides were added at gradient concentra-
tions from 10 nM to 10 mM to cells before addition of phages
during the process of biopanning. A randomly scrambled peptide
was used as a negative control. The binding ratio of phages to ES
cells was determined by the ratio of output titer of phages selected
by adding peptide normalized to the output titer of phages selected
without adding peptides. Each experiment was repeated three
times independently.
Immunofluorescence microscopy and internalization
assay
To further confirm the result of Whole-cell ELISA, immuncy-
tochemistry was carried out. ES, dES and PMEF cells plated in 24-
well plate (Falcon, Becton Dickinson Labware, Franklin Lakes, NJ)
were washed twice with PBS, fixed with 4% paraformaldehyde for
15 min at room temperature. After three washes with PBS, 2610
9
phages in 200 ml PBS, 1% BSA were added into each well. After
incubation for 90 min at 37uCo r2 5 uC, the plate was washed three
times with PBS, followed by the addition of Mouse anti-M13
antibody (1:1000 diluted in PBS, 1% BSA) for 1 hr at 37uC. The
plate was then washed three times with PBS, and incubated with
FITC-conjugated goat anti-mouse IgG (1:100 diluted in PBS, 1%
BSA) (Sigma-Aldrich) for 1 hr at 37uC in dark. Cells were
counterstained with Hoechest 33258 (Invitrogen) for 15 min and
photographed by an Eclipse TE2000 fluorescence microscopy
(Nikon). The photographs were processed with Image-Pro Plus
software (Media Cybernetics, Inc). The assay was performed
independently for three times. For the internalization assay, cells
were first incubated with 2610
9 phages in PBS/1% BSA, and then
washed with wash buffer (100 mM glycine, 0.5 M NaCl, 1% BSA,
pH 2.5) three times to wash away non-internalized phages, and
permeatedby0.1%TritonX-100beforeparaformaldehydefixation.
Western blotting
Total proteins from Rhesus ES cells were extracted by 20 mM
Tris, 200 mM NaCl, 1 mM EDTA, 0.5% NP-40, 1% SDS,
protease inhibitor cocktail (Roche, Nutley, NJ), and resolved on
12% SDS-PAGE gel, followed by electrophoretical transferring to
PVDF membrane (Millipore, Billerica, MA). The blot was blocked
with PBS, 5% BSA for 1 hr, and subsequently incubated with
2610
8 phagesinPBS,3%BSAforanotherhour. Afterthree washes
with PBS, the membrane was incubated with HRP-conjugate
mouse anti-M13 antibody (1:1000 dilution in PBS, 5% BSA) for
1 hr. The membrane was further developed with ECL western
blotting substrate (Pierce, Rockford, IL), and the signal was detected
by an Omega 12ic molecular imaging system (Ultra-LUM).
Quantum dot peptide conjugation and labeling cells
CdSe-ZnS core-shell quantum dots (QDs) were prepared
according to the previously published method [29]. The QDs
with emission maxima centered at 580 nm were conjugated with
peptides via covalent bonding using EDC. The peptides were
reacted with Sulfo-NHS bound QDs for 2 hr at room temperature
and then stored at 4uC. QD-labeled peptides were incubated with
cells to identify a specific binding ability of selected sequence. Cells
were plated in 1% gelatin coated 24-well plate. After adherence,
the cells were washed twice with PBS, mixed with 5 mL QD-
labeled peptide and 100 mL 4% paraformaldehyde in 400 mL
blocking buffer with gentle shaking at room temperature for 1 hr,
followed by washing three times with 0.1% Tween-20-PBS. Cells
were counterstained with Hoechest 33258 (Invitrogen) for 15 min
at room temperature and detected by FV1000 Confocal laser
scanning biological microscope (Olympus). Free quantum dots
without peptide conjugation were set as a negative control.
Molecular dynamics stimulation of peptide structure
Initially, an unfolded and fully extended structure was generated
by PROTEIN program in Tinker software (http://dasher.wustl.
edu/tinker/) [30] (backbone torsion Q, y=2135, 135), using
OPLS-AA force field parameters to assign the atom types. The
structure was subsequently optimized by Truncated Newton
Conjugate Gradient method using GB/SA continuum solvation
model. Afterward 1 ns molecular dynamics stimulation was carried
out at a time step of 2.0 fs, and the system thermostat temperature
was targeted to 298 K. The result of molecular dynamics
stimulation was further rendered with POV-RAY program.
Results
Screen of specific ES cell binding peptides by phage
display
Phages that specifically bound to ES cells were enriched in the
phage pool by four rounds of biopannings. Each round of
biopanning included three subtraction steps with dES cells, three
subtractions stepswith PMEFs andthena selection stepwith EScells
(Figure1). Duringfourrounds of biopannings, phage pools exhibited
decreasing binding efficiency to differentiated ES (dES) cells and
PMEFs. We observed the increasing recovery rate after subtraction,
from 43% up to 97%, indicating that the subtraction step in our
strategy was efficient to reduce non-specific binding of phages to ES
cells(Figure2A).Selectedphagepoolsalsoshowedincreasedbinding
efficiency to ES cells, from 8610
28 to 1610
24, indicating successful
accumulation of specific ES cell binding phages (Figure 2B).
After four rounds of biopannings, monoclonal phages were
randomly picked from the selected phage pool and the genomes of
the phages were sequenced. Of ten phage clones that had been
picked, three displayed the same peptide sequence APWHLSS-
QYSRT and four displayed peptides showed homologous sequence
with APWHLSSQYSRT (Figure 2C). The sequences of the peptide
region of the remaining three phages showed deletion (data not
shown).We noticed that a PWX(L/V) motif (Figure2C)co-exists in
the APW, GYP and LDV phages. This suggests that the specific
binding ability might be due to the PWX (L/V) motif. However
specificity it is not determined solely by the consensus motif but is
also through the coordination by other flanking amino acids since
the binding affinities of these phages are not identical.
Binding affinities and specificities of the purified phage
candidates were further analyzed by whole-cell ELISA. Of all
candidates the APW phage (APWHLSSQYSRT), GYP phage
(GYPHPWTLWHLN) and LDV phage (LDVRPWYVTPLP)
showed significantly greater binding efficiency to ES cells than
to dES cells, PMEFs and the negative control (p,0.01); the TPL
phage (TPLINMNALTVT) showed significant greater binding
efficiency as well (p,0.05), while the WAP phage (WAPEK-
DYMQLMK) showed no significantly specific binding (Figure 2D).
Since the APW phage showed the greates binding specificity to ES
cells and was most enriched in the phage pool, we decided to
further investigate and confirm its binding with ES cells.
Confirmation of the binding capability and specificity of
the selected phage to ES cells
In order to confirm our ES cell line is maintaining the
undifferentiated state, we first checked the undifferentiated state
Peptide-QDs Target ES Cells
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and clearly defined colonies as previously described [29]
(Figure 3A, left). Also, ES cell colonies were positive in the
alkaline phosphatase assay, another characteristic of undiffer-
entiated ES cells (Figure 3A, right). We then monitored the
expression levels of ES cell marker genes by RT-PCR. The
mRNAs of Octamer binding protein 4 (Oct-4), telomerase
reverse transcriptase (Tert), Nanog, and SRY (sex determining
region Y)-box 2 (Sox2) are expressed in the ES cell lines, further
confirming the undifferentiated state of ES cells (Figure 3B). In
order to determine whether ES cells are able to differentiate to
cells from all three germ layers, we tested the marker protein
expression in dES cells. The result showed that the dES cells
were positively stained with Nestin (ectoderm), Glial fibrillary
acidic protein (GFAP) (ectoderm), Vimentin (mesoderm), b-
tubulin (mesoderm) and alpha-fetoprotein (AFP) (endoderm),
indicating that the ES cells can be differentiated to all three
germ layers (Figure 3C). Additionally, the ES cells could form
the embryonic bodies in suspension culture system, showing
their pluripotency (Figure S1).
Immunofluorescence microscopy was performed to confirm that
the APW phage has the specific binding ability to ES cells. APW
phages were able to bind to ES cells (green signal in Figure 3D).
No obvious fluorescent signal of dES cells and PMEF cells was
observed. Wild type M13 phage did not bind to ES cells, as shown
in the control. We also carried out the internalization assay for
APW phages, which showed a weak signal (Figure 3D). GYP
phage and LDV phage also showed specific binding to ES cells;
however, their affinities were much lower when compared to the
APW phages (data not shown). We subsequently tested whether a
chemically synthesized peptide bearing the APWHLSSQYSRT
sequence could compete with the APW phage for the binding to
ES cells. As shown in Figure 3E, the chemically synthesized
APWHLSSQYSRT peptide was able to compete with the APW
phage, starting at the concentration of 100 nM and achieving 50%
inhibition at the concentration of about 500 nM. An
SLHSQPRSWTAY peptide with randomly scrambled sequence
of the APWHLSSQYSRT peptide failed to compete with the
APW phage for the binding to ES cells. These data demonstrate
that the binding ability of the phage to ES cells is caused by it
displaying the APWHLSSQYSRT peptide.
Targeting of ES cells by the peptide-quantuam dot
conjugates
CdSe-ZnS quantum dots were conjugated with the APWHLSS-
QYSRT peptide via stable covalent bonding using EDC, a
crosslinking agent that couples carboxyl groups to the amino
groups of the peptide (Figure 4A). We then investigated whether
Figure 1. Scheme of experiment design. Initially, phages that specifically bind to ES cells were enriched in phage pool by four rounds of
biopanning. Each round of biopanning included three subtraction steps with dES cells, three subtraction steps with PMEFs and a selection step with
ES cells. After enrichment, monoclonal phages were purified and screened by enzyme linked immunosorbent assay (ELISA). Phages that showed
higher binding ability and specificity were further confirmed with immunofluorescence microscopy. Then the selected peptide was chemically linked
with quantum dots and the subsequent peptide-quantum dot conjugates were tested for ES cell targeting.
doi:10.1371/journal.pone.0012075.g001
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By incubating the APWHLSSQYSRT peptide-quantum dots with
ES cells, followed by confocal laser scanning microscopy, we found
that the conjugates can bind to ES cells efficiently. As shown in
Figure 4B, the conjugates specifically target to the ES cell colonies
(inside dashed line) rather than the PMEF cells (outside dashed
line), which are used as a feeder layer. We also observed that the
peptide-quantum dot conjugates target the ES cell surface with
preference to the periphery of the cell surface, suggesting that the
binding is specific to a particular compartment of the ES cell
surface (Figure 4B, Bright-field image). In order to further test the
binding specificity of the APWHLSSQYSRT peptide-quantum
dots to ES cell lines, we assay the binding of the APWHLSS-
QYSRT peptide-quantum dots to a mouse ES cell line. As shown
in Figure 4C, the APWHLSSQYSRT peptide-quantum dots did
not bind to the mouse ES cell line. Also, there is no non-specific
binding of the quantum dots to the ES cells by using the peptide-
free quantum dots as the control.
Figure2.SelectionofPh.D-12phagepoolsagainstEScells.(A)SubtractionefficiencywithdEScellsandPMEFs.Thephagepoolunderwentthree
subtractions with dES cells and three subtractions with PMEFs in each round of biopanning. The efficiency is shown as the percentage of recovered
phage numbers from subtraction to input phage numbers. (B) Selection efficiency with ES cells. The binding efficiency of phage pool is shown as the
percentage of eluted phage numbers to input phage numbers in each round of biopanning. (C) Alignment of peptide sequences displayed by
monoclonal M13 phages selected binding to ES cells. Identical sequences are shown in color. (D) Affinity and specificity of purified candidate M13
phages binding to indicated cell types using ELISA. The peptides displayed by selected phages are APWHLSSQYSRT, GYPHPWTLWHLN, LDVRPWYVTPLP,
TPLINMNALTVT, andWAPEKDYMQLMK. Thefirstthree aminoacid letters of thesesequences areusedto standfor the correspondingphages. Results are
presented as absorption value (mean 6 standard derivation) in ELISA assay. Each experiment was repeated three times independently. **: p,0.01, and
*: p,0.05 using ANOVA test. BSA and M13 wild type phage (Wt) were used as the negative controls.
doi:10.1371/journal.pone.0012075.g002
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protein interation
To test whether the APW phage binds to ES cells through the
protein-protein interaction, proteins extracted from ES cells were
resolved on a 12% SDS-polyacrylamide gel and transferred to a
PVDF membrane. After incubation with APW phages, a major
band at 17 kDa and a minor band at about 15 kDa were observed
(Figure 5C).
To better understand the molecular architecture and biological
function of the APW peptide, we used the molecular dynamics
stimulation to initially characterize and predict its structure. After
1 ns of folding simulation, the peptide was folded into a compact
structure, with hydrophobic amino acid residuals facing one side
while hydrophilic residuals facing another (Figure 5A). Further-
more, Trp, Pro and Leu residuals were relatively close in the
spatial structure (Figure 5B). Combined with the fact that PWX
(L/V) motif might be important for the peptide binding mentioned
above, it is possible that the Trp, Pro and Leu residues form a
hydrophobic environment which can be recognized by certain cell
surface proteins.
Discussion
In the present study, we have described a method to enrich
phage pools that have specific binding efficiency and selectivity for
ES cells. In order to eliminate the possibility of selecting non-
relevant phages, we employed two steps of subtraction using dES
cells and PMEFs before each selection step. The result showed that
the subtraction is rather effective to exclude non-specific binding
phages. In addition, the method that we chose must pass through a
procedure of detaching cells from culture flasks by dispase or
trypsin, which is thought to possibly change the composition and
configuration of cell surface proteins [31]. To avoid the change of
cell surface proteins, we shortened the digestion time as far as
possible. We also tried the method using attached cells, however,
they were apt to detach during the incubation and the
concentration was much lower than that of suspended cells.
After the enrichment step, we picked several phages and
sequenced their peptide display gene region. We found an
APWHLSSQYSRT peptide sequence was the most accumulated
during biopannings and several peptides contain a PWX (L/V)
motif. The binding efficiency and specificity of the phage to ES
cells was tested by whole-cell ELISA and the result showed that the
APW phage served as a better candidate than other phages, which
was further verified by the immunofluorescent analysis. We
observed a phenomenon that these phages displayed a common
motif but showed different binding ability further suggests that the
motif is important for the binding while this binding ability is
coordinated by flanking sequences. Furthermore, the result that
the chemically synthesized APWHLSSQYSRT peptide could
inhibit binding of the phage to ES cells indicated that the specific
binding ability of APW phages was due to the displayed peptide
and independent of the phage itself. A BLAST search of the
sequence in the GeneBank showed several existing and/or
predicted homologous sequences (Table S1). In these sequences,
we find that several of them are of special interest. For example,
human Chorionic Gonadotropin (hCG) that shares the homology
with the APWHLSSQYSRT sequence is found to be important
for development and leishmanolysin-like protein is reported to
have the different expression pattern among different embryonic
stem cell lines [32], [33]. These findings suggest the APWHLSS-
QYSRT peptide might simulate protein-protein interaction.
To further characterize the phage and the displayed peptide, we
carried out western blotting. The result showed that the phage
bound to ES cells by protein-protein interaction, which is
consistent with the earlier report that peptides isolated from
phage display often bind to the sites by protein-protein interaction
[34], [35]. This finding also increases the possibility that the APW
peptide has the ability to target cell surface proteins, which is
possibly a membrane protein with a relatively low molecular
weight (about 17 kDa). Further in silico studies of the peptide
structure showed that the peptide contained a hydrophobic site
and had a hydrophilic environment on the other side, which
suggests that the peptide binds to ES cells via the non-bonding
forces. Since generally proteins contain the core hydrophobic
residues which are surrounded by a shell of hydrophilic residues, it
is possible that the PWX (L/V) motif is important for the
maintenance of tertiary structure of the peptide [36]. Combined
with our previous experiments and the in silico studies, it is possible
that the PWX (L/V) motif serves as an important core motif that
binds to the ES cell membrane proteins. Additionally, the in silico
studies of the peptide may open a perspective for improvement of
its binding affinity and specificity by redesigning of the peptide.
After conjugation with the peptide, the quantum dot showed a
much higher binding ability to ES cells compared to the naked
quantum dots, suggesting that adding the peptide can increase
quantum dot binding affinity and specificity towards ES cells.
Moreover, the fact that the peptide-conjugated quantum dots were
unable to target mouse ES cell line further suggests their specificity
towards a particular cell line.
In general, there are two major concerns in nanoparticles cell-
targeting studies: specificity and toxicity. To increase the specificity
of nanoparticles to cells, there could be targeting materials
designed to link with the nanoparticles. Phage display is a useful
tool for searching for the targeting materials. Our group and
several other groups have successfully found peptides or antibodies
that can specifically recognize a variety of stem cells using phage
display [12], [13], [37], [38], [39]. However, it is still an open
question that how specific these peptides or antibodies are.
Although in our study, the selected peptide was unable to bind to
the stem cell line of the other species, further proves its specificity,
we still observed that several peptides with ‘‘homologous core
sequence’’, namely the PWX (L/V) motif, were able to bind to
differentiated ES cells, albeit with low efficiency. Although this
might be due to the incomplete differentiation of ES cells or the ES
cells slightly differentiated during the selection step, so that some
types of differentiated cells can not be distinguished from ES cells,
it also possible that the recognition specificity to a particular cell is
Figure 3. Confirmation of binding affinity and specificity of selected phage to ES Cells. (A) Bright-field image of an ES cell colony and
alkaline phosphotase characterization of ES cell colonies. (B) RT-PCR detection of ES cell marker gene expression. (C) Immunofluorescence and
immunochemistry detection of differentiated ES cell markers. (D) Immunofluorescence microscopy of APW phage binding to ES cells, dES cells and
PMEFs. APW phage binding ability to ES cells was tested at both 37uC and 25uC. Binding ability of APW phage to dES cells and PMEFs as well as
internalization of APW phage by ES cells were tested at 37uC. Wildtype M13 phage was used as a control. The immunofluorescence signal of M13
phage is shown in green. Cell nuclei were counter-stained with Hoechest 33258 (blue). (E) Competition of APW phage binding by chemically
synthesized peptides, APWHLSSQYSRT and SLHSQPRSWTAY. Increasing concentrations of the peptide from 10 nM to 10 mM were added to 2610
6 ES
cells before addition of 1610
10 APW phages. Binding ratio was determined by output titer of phages with addition of peptides normalized to that
without addition of peptides. Each experiment was repeated three times and the values were shown as mean 6 standard derivation.
doi:10.1371/journal.pone.0012075.g003
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possibly influenced by the flanking sequences of the core motif. By
engineering the flanking sequences of the peptide, it is quite
possible to increase the specificity of the peptide recognition and
the in silico study might provide a possible direction for the
engineering. Another concern of the nanoparticle cell-targeting
study is the toxicity. Previous studies have shown that coating is
the most important factor for cytotoxicity of the quantum dots
[40], [41]. Another study has shown that the toxicity and
metabolism of the quantum dots are different in different type of
cells [42]. These studies suggest that the cytotoxicity of quantum
dots can be minimized by proper coating technique and selection
Figure 4. Targeting of ES cells by peptide-conjugated quantum dots. (A) Scheme of the peptide-conjugated quantum dots. (B) Bright-field
and fluorescence microscopy of APWHLSSQYSRT peptide-conjugated quantum dots targeting ES cells. Dashed circle shows an ES cell colony. The
fluorescence signal of peptide-conjugated quantum dots is shown in red and cell nuclei are shown in blue (Hoechest 33258). PMEF cells and
quantum dots without conjugation of peptides were set as the controls. Scale bar, 100 mm. (C) Fluorescence microscopy of APWHLSSQYSRT peptide-
conjugated quantum dots with mouse ES (mES) cells. The binding of APWHLSSQYSRT peptide-conjugated quantum dots to mES cells were
undetectable. Free quantum dots without conjugation of peptides were set as the control. Scale bar, 100 mm.
doi:10.1371/journal.pone.0012075.g004
Peptide-QDs Target ES Cells
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of interest. However, the toxicity of the peptide-quantum dot
conjugates remains to be investigated. Although previous studies
have shown that targeting of CdSe-ZnS to other type of cells does
not change their cellular morphology and physiology [28], [43],
[44], the physiological effect of the peptide-quantum dot
conjugates on ES cells is unknown.
In summary, we have established a method of screening for ES
cell binding peptides by phage display and identified a novel
peptide that specifically binds to ES cells. This peptide holds the
promise to be a targeting or imaging agent for ES cells and might
serve as a novel research tool for studying the ES cell surface as
well. However, further studies are needed to understand the
biology of the APWHLSSQYSRT peptide. Work is continuing to
further assess its specificity using more cell types, to test whether
this binding ability is the same in vivo as in vitro, to measure the
toxicity of the peptide-quantum dot conjugates on ES cells and
determine whether the peptide has a physiological effect on ES
cells.
Supporting Information
Figure S1 Embryonic body (EB) formation by differentiated
embryonic stem cells. From day 1 to day 3, suspended cultured ES
cells aggregate and form simple EB. After day 4, the EB form basal
lamina (smoothen edge) and a central cavity occurs.
Found at: doi:10.1371/journal.pone.0012075.s001 (1.86 MB TIF)
Table S1 Homological sequences identified by protein database
search.
Found at: doi:10.1371/journal.pone.0012075.s002 (0.03 MB
DOC)
Table S2 Summary of RT-PCR primers for detection of
undifferentiated ES cell marker gene expression.
Found at: doi:10.1371/journal.pone.0012075.s003 (0.03 MB
DOC)
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